IFN-γ enhances osteoclast generation cultures of peripheral blood from osteopetrotic patients and normalizes superoxide production

Journal of Interferon and Cytokine Research

Volumn 20, Issue 7, 2000, Pages 645-652

  Madyastha, Prema R ^a   Yang, S U ^a   Ries, William L ^a   Key Jr , L Lyndon ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN RECEPTOR; GAMMA INTERFERON; SUPEROXIDE;

ALBERS SCHOENBERG DISEASE; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL;

ACID PHOSPHATASE; ADULT; ANIMALS; CALCITONIN; CALCITRIOL; CATTLE; CELL DIFFERENTIATION; CELL SIZE; CELLS, CULTURED; CHILD, PRESCHOOL; CULTURE MEDIA; DEXAMETHASONE; HUMANS; INFANT; INTERFERON TYPE II; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; MACROPHAGE COLONY-STIMULATING FACTOR; OSTEOCLASTS; OSTEOPETROSIS; RECEPTORS, CALCITONIN; REFERENCE VALUES; SUPEROXIDES;

BOVINAE;

EID: 0033912344     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999000414826     Document Type: Article

References (34)

1. SHAPIRO, F., GLIMCHER, M.J., HOTROP, M.E., TASHJIAN, A.H., BRICKLEY-PARSONS, D., and KENZORA, J.E. (1980). Human osteopetrosis: a histological, ultrastructural, and biochemical study. J. Bone Joint Surg. 62, 384-399.
2. KEY, L.L., WOLF, W.C., GUNDBERG, CM., and RIES, W.L. (1994). Superoxide and bone resorption. Bone 15, 431-436.
3. REEVES, J.D., AUGUST, C.S., HURBET, T., Jr., and WESTON, W.L. (1979). Host defense in infantile osteopetrosis. Pediatrics 64, 202-206.
4. BEARD, C.J., KEY, L.L., NEWBERGER, P.E., EZKOWITZ, A.B., ARECI, R., MILLER, B., PROTO, P., TYAN, T., ANAST, C, and SIMMONS, E.R. (1986). Neutrophil defect associated with malignant infantile osteopetrosis. J. Clin. Lab. Med. 109, 498-505.
5. KEY, L.L., and RIES, W.L. (1993). Osteopetrosis: the pharrnaco-physiologic basis of therapy. Clin. Orthoped. Rel. Res. 294, 85-89.
6. KEY, L.L.,RIES, W.L., RODRIGUIZ, R.M., and HATCHER, H.C. (1992). Recombinant human interferon gamma therapy for osteopetrosis. J. Pediatr. 121, 119-124.
7. KEY, L.L., RODRIGUIZ, R.M., WILLI, S.M., WRIGHT, N.M., HATCHER, H.C., EYRE, D.R., CURE, J.K., GRIFFIN, P.P., and RIES, W.L. (1995). Long-term treatment of osteopetrosis with recombinant human interferon gamma. N. Engl. J. Med. 332, 1594-1599.
8. EZEKOWITZ, R.A.B., ORKIN, S., and NEWBERGER, P.N. (1988). Recombinant interferon gamma augments phagocyte superoxide production and gene expression in X-linked chronic granulomatosis disease by subcutaneous interferon gamma. N. Engl. J. Med. 319, 146-151.
9. GOWEN, M., NEDWIN, G.E., and MUNDY, G.R. (1986). Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gamma. J. Bone Miner. Res. 1, 469-174.
10. GOWEN, M., and MUNDY, G.R. (1986). Actions of recombinant interleukin-l, interleukin-2, and interferon gamma on bone re sorption in vitro. J. Immunol. 136, 2472-2482.
11. LERNER, U.H., LJUNGRENN, O., RANSJO, M., KLAUSHOFER, K., and PETERLIK, M. (1991). Inhibitory effects of gamma-interferon bradykinin-induced bone resorption and prostaglandin formation in cultured mouse calvarial bones. Agents Actions 32, 305-311.
12. MUNDY, G.R. (1993). Role of cytokines in bone resorption. J. Cell. Biochem. 53, 296-300.
13. FUJIKAWA, Y., QUINN, J.M.W., SABOKBAR, A., McGEE, J.O.D., and ATHANASOU, N.A. (1996). The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137, 4058-4060.
14. MATAYOSHI, A., BROWN, C., DIPERSIO, J.F., HAUG, J., ABU-AMER, Y., LIAPIS, H., KUESTNER, R., and PACIFICI, R. (1996). Human blood mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells. Proc. Natl. Acad. Sci. USA 93, 10785-10790.
15. 3. J. Bone Miner. Res. 8, 61-70.
16. COURNOT, G., GARABEDIAN, M., THIL, C.L., FERNANDEZ-DELGADO, R., BLANCHE, S., and BALSAN, S. (1987). In vitro osteoclast-like formation from peripheral blood monocytes of osteopetrotic children. Calcif. Tissue Int. 41, (Suppl. 2), OP33.
17. 3 in osteoclast differentiation and function. Methods Enzymol. 282, 223-235.
18. SHALHOUB. V., FAUST, J., BOYLE, W.J., DUNSTAN, C.R., KELLEY, M., KAUFMAN, S.S., VAN, G., and LACEY, D.L. (1999). Osteoprotegrin and osteoprotegrin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. J. Cell. Biochem. 72, 251-261.
19. NICHOLSON, G.C., MOSELEY, J.M., SEXTON, P.M., MENDELSSOHN, F.A.O., and MARTIN, T.J. (1986). Abundant calcitonin receptors in isolated osteoclasts. J. Clin. Invest. 78, 355-360.
20. KASTEN, T.P., COLLIN-OSDOBY, P., PATEL, N., OSDOBY, P., KRUKOWSKI, M., MISKO, T.P., SETTLE, S.L., CURRIE, M.G., and NICKOLS, G.A. (1994). Potentiation of osteoclast boneresorption activity by inhibition of nitric oxide synthase. Proc. Natl. Acad. Sci. USA 91, 3569-3573.
21. WALSH, C.A., BERESFORD, J.N., BIRCH, M.A., BOOTH- ROYD, B., and GALLAGHER, J.A. (1991). Application of reflected light microscopy to identify and quantitate resorption by isolated osteoclasts. J. Bone Miner. Res. 6, 661-671.
22. KEY, L.L., RIES, W.L., TAYLOR, R.G., HAYS, B.D., and PITZER, B.L. (1990). Oxygen-derived free radicals in osteoclasts: the specificy and location of the nitroblue tetrazolium reaction. Bone 11, 115-119.
23. RIES, W.L., KEY, L.L., and RODRIGUIZ, R.M. (1992). Nitroblue tetrazolium reduction and bone resorption by osteoclasts in vitro inhibited by a manganese-based Superoxide dismutase mimic. J. Bone Miner. Res. 7, 931-939.
24. GARRETT, I.R., BOYCE, B.F., OREFFOR, O.C., BONEWAL, D.L., POSTER, J., and MUNDY, G.R, (1990). Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone m vitro and in vivo. J. Clin. Invest. 85, 632-639.
25. AKATSU, T., TAMURA, T., TAKAHASHI, N., UDAGAWA, N., TANAKA, S., SASAKI, T., YAMAGUCHI, A., NAGATA, N., and SUDA, T. (1992). Preparation and characterization of a mouse osteoclast-Iike multinucleated cell population. J. Bone Miner. Res. 7, 1297-1306.
26. JEAN-PIERRE, D., NEFF, L., CHEN, Y., RINCON. M.. HORNE, W.C., and BARON, R. (1998). A new method to isolate large numbers of rabbit osteoclasts and osteoclast-like cells: application to the characterization of serum response element binding proteins during osteoclast differentiation. J. Bone Miner. Res. 13, 1730-1738.
27. MADYASTHA, P.R., YANG, S., RIES, W.L., and KEY, L.L. (1999). Normalization of Superoxide generation in human osteopetrotic osteoclasts is mediated by the direct binding of interferon gamma to the osteoclastic cell surface receptors. J. Bone Miner. Res. 14, S359.
28. TAKAHASHI. N., MUNDY, G.R., and ROODMAN, G.D. (1986). Recombinant human gamma interferon inhibits formation of osteoclast-like cells by inhibiting fusion of their precursors. J. Immunol. 137, 3544-3549.
29. ROODMAN, G.D. (1993). Role of cytokines in the regulation of bone resorption. Calcif. Tissue Int. 53 (Suppl. 1), S94-S98.
30. CASSATELLA, M.A., CAPPELLI, R., DELLA BIANCA, V., GRZESKOWICK, M., DUSI, S., and BERTON, G. (1988). Interferon-gamma activates human neutrophil oxygen metabolism and exocytosis. Immunology 63, 499-506.
31. MORRISON, C.J., BRUMMER, E., ISENBERG, M.A., and STEVENS, D.A. (1987). Activation of murine polymorphonuclear neutrophils for fungicidal activity by recombinant gamma interferon. J. Leukocyte Biol. 41, 434-440.
32. MARTIN, W.J., QADEK, J.E., HUNNINGHAKE, G.W., and CRYSTAL, R.G. (1981). Oxidant injury of lung parenchymal cells. J. Clin. Invest. 68, 1277-1288.
33. 2 metabolites cause reperfusion injury after short but not prolonged renal ischemia. Am. J. Physiol. 253, F685-F691.
34. LUCCHESI, B.R., and MULLANE, K.M. (1986). Leukocytes and ischemia-induced myocardial injury. Annu. Rev. Pharmacol. Toxicol. 26, 201-224.